You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lonafarnib

Showing 1 - 25 of 39
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Delta Hepatitis Trial (lonafarnib, Ritonavir)

Completed
  • Chronic Delta Hepatitis
  • (no location specified)
Dec 12, 2022

Chronic Hepatitis Delta Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (Peginterferon

Not yet recruiting
  • Chronic Hepatitis Delta
  • Peginterferon Lambda
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 25, 2023

Hepatitis D, Chronic Trial in Be'er Sheva, Auckland, Istanbul (Lonafarnib, Ritonavir)

Recruiting
  • Hepatitis D, Chronic
  • Be'er Sheva, Israel
  • +2 more
Jan 27, 2022

Liver Disease, Hepatitis D Trial run by the NIDDK (Peg-interferon lambda, Lonafarnib, Ritonavir)

Completed
Has Results
  • Liver Disease
  • Hepatitis D
  • Peg-interferon lambda
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 6, 2021

Progeria Trial in Boston (Everolimus and lonafarnib)

Enrolling by invitation
  • Progeria
  • Everolimus and lonafarnib
  • Boston, Massachusetts
    Boston Children's Hospital
Jun 11, 2021

Malignant Supratentorial Tumor, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (Lonafarnib, Temozolomide)

Active, not recruiting
  • Malignant Supratentorial Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2021

Progeria, HGPS Trial (Lonafarnib)

Approved for marketing
  • Progeria
  • HGPS
  • Lonafarnib
  • (no location specified)
Apr 13, 2021

Chronic Delta Hepatitis Trial (Lonafarnib, Ritonavir)

Withdrawn
  • Chronic Delta Hepatitis
  • (no location specified)
Feb 12, 2021

Hepatitis Delta Virus Trial in Worldwide (Lonafarnib, Ritonavir, PEG IFN-alfa-2a)

Recruiting
  • Hepatitis Delta Virus
  • Lonafarnib
  • +4 more
  • Fresno, California
  • +117 more
Sep 30, 2021

Liver Cancer Trial (gemcitabine HCl, lonafarnib, conventional surgery)

Withdrawn
  • Liver Cancer
  • gemcitabine hydrochloride
  • +2 more
  • (no location specified)
Jul 29, 2020

Progeria, Hutchinson-Gilford Syndrome Trial in Boston (Lonafarnib)

Completed
Has Results
  • Progeria
  • Hutchinson-Gilford Syndrome
  • Lonafarnib
  • Boston, Massachusetts
    Children's Hospital Boston
Jun 11, 2019

Progeria, Hutchinson-Gilford Syndrome Trial in Boston (Lonafarnib, Zoledronic Acid, Pravastatin)

Completed
Has Results
  • Progeria
  • Hutchinson-Gilford Syndrome
  • Lonafarnib
  • +2 more
  • Boston, Massachusetts
    Children's Hospital Boston
Jun 11, 2019

Viral Hepatitis B, Viral Hepatitis D, Cirrhosis, Liver Trial in Worldwide (REP 2139-Mg, Tenofovir Disoproxil Fumarate, Pegylated

Available
  • Viral Hepatitis B
  • +6 more
  • REP 2139-Mg
  • +2 more
  • Vienna, Austria
  • +12 more
Feb 1, 2023

Chronic Myelogenous Leukemia Trial in Houston (Lonafarnib (SCH66336), Imatinib Mesylate (Gleevec))

Completed
  • Chronic Myelogenous Leukemia
  • Lonafarnib (SCH66336)
  • Imatinib Mesylate (Gleevec)
  • Houston, Texas
    M.D. Anderson Cancer Center
Nov 6, 2018

Hepatitis D Trial run by the NIDDK (Lonafarnib, Ritonavir, Placebo)

Completed
Has Results
  • Hepatitis D
  • Lonafarnib
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 27, 2018

Disease Loads and Status of Treatment

Recruiting
  • Chronic Hepatitis B
  • +2 more
  • Prospective serological assays
  • Retrospective serological assays
  • Taipei City, Taiwan
    National Taiwan University Hospital
Feb 28, 2022

Colorectal Cancer, Metastatic Cancer Trial (SCH 66336, conventional surgery)

Withdrawn
  • Colorectal Cancer
  • Metastatic Cancer
  • SCH 66336
  • conventional surgery
  • (no location specified)
Nov 13, 2018

Head Neck Cancer Trial in Houston (Fenretinide (4-HPR), SCH66336)

Terminated
  • Head and Neck Cancer
  • Houston, Texas
    UT MD Anderson Cancer Center
Nov 14, 2018

Chronic Hepatitis D Infection Trial in Ankara (lonafarnib, Ritonavir, PEG IFN-a)

Completed
  • Chronic Hepatitis D Infection
  • lonafarnib
  • +2 more
  • Ankara, Turkey
    Ankara University Medical School
Jul 27, 2017

Carcinoma, Squamous Cell, Cancer of Head and Neck Trial in Houston (SCH66336)

Completed
  • Carcinoma, Squamous Cell
  • Cancer of Head and Neck
  • Houston, Texas
    The University of Texas M. D. Anderson Cancer Center
Oct 29, 2018

Myelogenous Leukemia, Chronic Trial in Houston (SCH66336)

Completed
  • Myelogenous Leukemia, Chronic
  • Houston, Texas
    MDAnderson Cancer Center
Oct 29, 2018

Chronic Hepatitis D Infection Trial in Ankara (lonafarnib, PEG IFN-a, Ritonavir)

Completed
  • Chronic Hepatitis D Infection
  • lonafarnib
  • +2 more
  • Ankara, Turkey
    Ankara University Medical School
Jan 18, 2017

Glioblastoma Multiforme Trial in Houston (Temozolomide and SCH66336)

Completed
  • Glioblastoma Multiforme
  • Temozolomide and SCH66336
  • Houston, Texas
    UTMD Anderson Cancer Center
Oct 25, 2018

Hepatitis D Trial run by the NIDDK (Lonafarnib, Placebo)

Completed
Has Results
  • Hepatitis D
  • Lonafarnib
  • Placebo
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 18, 2016

Metastatic Breast Cancer Trial in United States (Lonafarnib)

Terminated
Has Results
  • Metastatic Breast Cancer
  • Lonafarnib
  • Galesburg, Illinois
  • +5 more
Jan 21, 2016